article · Journal of Medical and Surgical Research
Background: Maintaining optimal glycemic control is a primary goal in the management of type 2 diabetes, especially among overweight and obese patients. The objective of the study was to explore the relationship between overweight/obesity and glycemic control (HbA1c) among patients diagnosed with diabetes mellitus and admitted to the reference center for chronic diseases in Oujda. Methods: This is a retrospective cohort study including all type 2 diabetic patients who had at least 2 consultations between 2005 and December 2020. Results: 5123 patients were included in the study, 71.6% were women with an average age of 56.6 ± 11.8 years and 54.8% had diabetes for more than 2.5 years. Arterial hypertension was present in 38.3% at admission, 43.2% were overweight and 30.1% were obese. Almost 16.3% of patients had at least one complication on admission, 3.5% had heart disease, 5% had nephropathy, 3.9% retinopathy, 1.3% neuropathy and 0.6 % had a diabetic foot. During the 2nd visit, almost a quarter (23.7%) of overweight/obese patients had good glycemic control versus 20.5% in patients with an underweight or normal weight patients (p=0.035) with a more marked decrease of HbA1C between the 1st and the 2nd visit in overweight/obese patients (8.9±0.1% versus 8.8± 0.1%, p=0.054) compared to underweight or normal weight patients (9.4± 0.1% versus 9.3± 0.1%, p=0.318). The overweight/obese patients were significantly younger than the others (55.4±11.3 years versus 56.7 ±9.4 years, p=0.002), with more comorbidities, more history of hypertension (39.7% versus 28%, p
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.46327/msrjg.1.000000000000245
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.